CCR5 and inflammatory bowel disease: Patients with IBD have increased CCL2 expression level (52–54), and CCL5 attracts CCR1 and CCR5-expressing inflammatory cells into colon tissue of trinitrobenzene sulphonic acid (TNBS)-induced colitis mice model (55).